ReviewFrontiers in pharmacology2026

Therapeutic advances in eculizumab for atypical hemolytic uremic syndrome: a narrative review.

Dandan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.